---
title: "Wall Street calls: Piper upgrades Rivian, Mobileye; JPMorgan starts Rhythm Pharmaceuticals at overweight"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293931775.md"
description: "Piper Sandler upgraded Rivian and Mobileye to overweight, citing improved fundamentals and valuation. JPMorgan initiated Rhythm Pharmaceuticals at overweight with a $145 price target. Other notable calls include Williams-Sonoma (overweight), Sonida Senior Living (outperform), Aduro Clean Technologies (buy), and Cameco (upgrade to buy)."
datetime: "2026-07-27T12:18:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293931775.md)
  - [en](https://longbridge.com/en/news/293931775.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293931775.md)
---

# Wall Street calls: Piper upgrades Rivian, Mobileye; JPMorgan starts Rhythm Pharmaceuticals at overweight

According to CNBC, Piper Sandler upgraded Rivian and Mobileye to overweight from neutral, saying both stocks are compelling. Piper cited Rivian's de-risked balance sheet, a smooth R2 ramp and an improved demand outlook, while saying Mobileye is nearing floor valuation and gaining control of its own destiny. The firm also initiated Williams-Sonoma at overweight with a $253 price target, and JPMorgan started Rhythm Pharmaceuticals at overweight with a Dec. 27 price target of $145. Other calls included Citizens' initiation of Sonida Senior Living at market outperform, Roth's initiation of Aduro Clean Technologies at buy, and UBS's upgrade of Cameco to buy from neutral after a recent pullback.

### Related Stocks

- [SNDA.US](https://longbridge.com/en/quote/SNDA.US.md)
- [WSM.US](https://longbridge.com/en/quote/WSM.US.md)
- [PIPR.US](https://longbridge.com/en/quote/PIPR.US.md)
- [RYTM.US](https://longbridge.com/en/quote/RYTM.US.md)
- [RIVN.US](https://longbridge.com/en/quote/RIVN.US.md)
- [MBLY.US](https://longbridge.com/en/quote/MBLY.US.md)
- [ADUR.US](https://longbridge.com/en/quote/ADUR.US.md)
- [CCJ.US](https://longbridge.com/en/quote/CCJ.US.md)
- [RVNL.US](https://longbridge.com/en/quote/RVNL.US.md)
- [JPM.US](https://longbridge.com/en/quote/JPM.US.md)
- [CFG.US](https://longbridge.com/en/quote/CFG.US.md)
- [UBS.US](https://longbridge.com/en/quote/UBS.US.md)
- [JPM-M.US](https://longbridge.com/en/quote/JPM-M.US.md)
- [JPM-C.US](https://longbridge.com/en/quote/JPM-C.US.md)
- [JPM-D.US](https://longbridge.com/en/quote/JPM-D.US.md)
- [JPM-L.US](https://longbridge.com/en/quote/JPM-L.US.md)
- [8634.JP](https://longbridge.com/en/quote/8634.JP.md)
- [JPM-K.US](https://longbridge.com/en/quote/JPM-K.US.md)
- [JPM-J.US](https://longbridge.com/en/quote/JPM-J.US.md)
- [CFG-I.US](https://longbridge.com/en/quote/CFG-I.US.md)
- [CFG-E.US](https://longbridge.com/en/quote/CFG-E.US.md)
- [CFG-H.US](https://longbridge.com/en/quote/CFG-H.US.md)

## Related News & Research

- [RIVN Stock Alert: What to Know as Rivian Sues for Refund of Trump Tariffs](https://longbridge.com/en/news/293793238.md)
- [Bad news Rivian R2 flippers, one of the first models only fetched $63k](https://longbridge.com/en/news/293812157.md)
- [Rivian (RIVN) Q2 Earnings: What To Expect](https://longbridge.com/en/news/294145202.md)
- [Rivian reduces 2026 spending plans, narrows earnings guidance](https://longbridge.com/en/news/294409084.md)
- [Rivian Stock (RIVN) Outlook: What Technical Analysis Says Ahead of Q2 Earnings Tomorrow](https://longbridge.com/en/news/294270001.md)